CLINICAL ROLE -
Pharmacogenomics Update: Working Group Guideline for Gene-Drug Interactions Between CYP2D6, CYP3A4, and CYP1A2 With Antipsychotics
Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.
Read More